Allogeneic Hematopoietic Stem Cell Transplantation Hsct clinical trials

Explore recruiting allogeneic hematopoietic stem cell transplantation hsct clinical trials.

Recruiting allogeneic hematopoietic stem cell transplantation hsct studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Allogeneic Hematopoietic Stem Cell Transplantation Hsct trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

DK-CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19 positive hematological malignancies (DAN-CART 1901)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

GRAALL 2024 - A 3-cohort Randomized Study evaluating the role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults with Acute Lymphoblastic Leukemia

Belgium, France

Phase II and Phase III (Integrated) EU CTIS Study details

A multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients: efficacy and microbiologic safety.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Allogeneic Hematopoietic Stem Cell Transplantation Hsct trials by city

Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Toronto Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Vancouver Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Montreal Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Calgary Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Edmonton Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Ottawa Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Winnipeg Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Quebec City Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Hamilton Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Kitchener Allogeneic Hematopoietic Stem Cell Transplantation Hsct in London Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Halifax Allogeneic Hematopoietic Stem Cell Transplantation Hsct in New York Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Los Angeles Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Chicago Allogeneic Hematopoietic Stem Cell Transplantation Hsct in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease